John Burns
Director of Finance/CFO chez SELLAS LIFE SCIENCES GROUP, INC.
Fortune : 94 352 $ au 31/03/2024
Profil
John T.
Burns is currently the Chief Financial Officer & Accounting Officer, SVP at SELLAS Life Sciences Group, Inc. He previously worked as the Manager-Securities & Exchange Reporting at Pixelworks, Inc. and as the Chief Accounting Officer at Galena Biopharma, Inc. Mr. Burns completed his undergraduate and graduate degrees at Tulane University (Louisiana).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/01/2024 | 93 418 ( 0,17% ) | 94 352 $ | 31/03/2024 |
Postes actifs de John Burns
| Sociétés | Poste | Début |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 30/12/2017 |
Anciens postes connus de John Burns
| Sociétés | Poste | Fin |
|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Formation de John Burns
| Tulane University (Louisiana) | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
